Ocular Therapeutix
Patents, Design & Utilities
Last updated:
List of all Ocular Therapeutix patents 12 in total
| Status | Patent |
|---|---|
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES Filling date: 7 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: METHODS OF TREATING ALLERGIC CONJUNCTIVITIS Filling date: 7 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE Filling date: 7 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: OCULAR INSERT CONTAINING A GLUCOCORTICOID Filling date: 7 Sep 2025 Issue date: 16 Jun 2022 |
Grant | Utility: Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine Filling date: 7 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine Filling date: 7 Sep 2025 Issue date: 5 Apr 2022 |
Application | Utility: SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE Filling date: 7 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR Filling date: 7 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: Compositions and Methods for Treating Ocular Diseases Filling date: 7 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: INTRACANALICULAR HYDROGEL INSERTS FOR THE DELIVERY OF ANESTHETICS Filling date: 7 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: HYDROGEL IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE Filling date: 7 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS Filling date: 7 Sep 2025 Issue date: 29 Oct 2020 |
Showing 1 to 12 of 12 patents.